ZIRABEV
Аналоги ZIRABEV
Найдите более доступные аналоги и дженерики для ZIRABEV.
Активный ингредиент: BEVACIZUMAB
Описание товара
About ZIRABEV
ZIRABEV is a prescription medicine used to treat certain types of cancer, including colorectal, lung, breast, kidney, and liver cancers. It is specifically designed to target and inhibit the action of vascular endothelial growth factor (VEGF), a protein that promotes the growth of new blood vessels that feed tumors.
Key Benefits & Uses
- Treatment of metastatic colorectal cancer in combination with 5-fluorouracil (5-FU) and leucovorin (LV)
- Treatment of non-small cell lung cancer (NSCLC) in combination with carboplatin and paclitaxel
- Treatment of breast cancer in combination with paclitaxel
- Treatment of renal cell carcinoma (RCC) in combination with interferon alfa
- Treatment of hepatocellular carcinoma (HCC)
Active Ingredient & Action
ZIRABEV contains bevacizumab, a recombinant humanized monoclonal antibody that specifically binds to VEGF. By inhibiting VEGF, bevacizumab reduces the formation of new blood vessels that supply the tumor, thereby slowing down tumor growth and metastasis.
Important Notes
ZIRABEV is administered intravenously and should only be used under the guidance of a qualified healthcare professional. Patients with a history of hemoptysis, hypertension, or proteinuria should be closely monitored. Common side effects include hypertension, proteinuria, and headache.
Оценки посетителей
Помогите другим — оцените полезность этой страницы.
Оценок пока нет — будьте первым.